On June 12, 2009, Genaera Corporation transferred all of its assets and liabilities to the Genaera Liquidating Trust in accordance with the Plan of Complete Liquidation and Dissolution adopted at a Special Meeting of Stockholders on June 4, 2009. Details of the Plan of Dissolution are described in the proxy statement for the Special Meeting. The proxy statement and a copy of the Liquidating Trust Agreement may be found in the Company filings section of the SEC website at www.sec.gov.

Persons having business with Genaera Corporation or the Genaera Liquidating Trust may contact the Trustee at trustee@genaera.com or:

Genaera Liquidating Trust
610 Second Street Pike
Southampton, PA 18966
Phone: 267-988-4079
Fax: 267-988-4082


Links to documents of potential interest to unitholders and prospective purchasers of drug development assets are set forth below.

Click here to view the Non-Confidential Executive Summary -- IL-9 Antibody Program

Click here to view the Non-Confidential Executive Summary -- Pexiganan


Click here to view the Letter Sent to Unit Holders in August 2009

Click here to view the Trustee’s Most Recent Update to Unit Holders

Click here to view the Trustee’s August 12, 2009 Update to Unit Holders

Click here to view The Genaera Liquidating Trust FAQ's